文献速递呼吸衰竭与机械通气儿科与产科急症

定量肺超声指导晚期早产及足月新生儿表面活性物质治疗

Quantitative Lung Ultrasonography to Guide Surfactant Therapy in Neonates Born Late Preterm and Later.
PubMed 文献 · JAMA Netw Open · 2024-05-01
一句话结论对生后早期呼吸衰竭的≥34周新生儿,肺超声评分>8分与最高总体准确度相关,作者认为可用于指导表面活性物质给药。

这项前瞻性国际多中心诊断研究于2022年12月至2023年11月在法国、意大利、西班牙和美国的学术性新生儿重症监护病房开展,纳入157例≥34周孕周、生后早期出现呼吸衰竭的新生儿,在生后中位3小时(IQR 2-7小时)行床旁肺超声计算新生儿肺超声评分(LUS,范围0-18,分值越高通气越差),结果不用于临床决策。32例(20.4%)需要表面活性物质(检验前概率20%),LUS预测需表面活性物质的AUC为0.87(95%CI 0.81-0.92);作为替代检查时LUS>8分总体准确度最高,作为分诊检查时LUS≤4分敏感度最高。晚期早产儿(AUC 0.89;95%CI 0.81-0.97;n=111)与早期足月及以后(AUC 0.84;95%CI 0.73-0.96;n=46)亚组诊断准确度相似。校正孕周后LUS与SpO2:FiO2(校正β -10.4;95%CI -14.0至-6.7;P<.001)及OSI(校正β 0.2;95%CI 0.1-0.3;P<.001)显著相关。

要点

  • ≥34周呼吸衰竭新生儿中,LUS预测需表面活性物质的AUC为0.87(95%CI 0.81-0.92),32/157例(20.4%)实际需要给药。
  • LUS>8分时总体准确度最高(替代检查用途),作者据此提出LUS可指导表面活性物质给药。
  • LUS≤4分时敏感度最高(分诊用途),作者认为该人群需要表面活性物质的可能性不大。
  • 晚期早产儿(AUC 0.89;95%CI 0.81-0.97;n=111)与早期足月及以后(AUC 0.84;95%CI 0.73-0.96;n=46)诊断准确度相似。
  • 校正孕周后LUS与SpO2:FiO2(校正β -10.4;95%CI -14.0至-6.7;P<.001)和OSI(校正β 0.2;95%CI 0.1-0.3;P<.001)显著相关。

适用人群与场景

  • ≥34周孕周的晚期早产至足月新生儿,生后早期出现呼吸衰竭,纳入法国、意大利、西班牙和美国的学术性新生儿重症监护病房。
  • 研究在生后中位3小时(IQR 2-7小时)行床旁肺超声。

诊断标准与关键阈值

  • 新生儿肺超声评分(LUS)范围0-18分,分值越高提示通气越差。
  • LUS>8分与最高总体准确度相关(替代检查用途),作者认为可用于指导表面活性物质给药。
  • LUS≤4分与最高敏感度相关(分诊检查用途),作者认为该人群需要表面活性物质的可能性不大。

研究设计与关键结果

  • 前瞻性、国际、多中心诊断研究,2022年12月至2023年11月纳入157例(男96例,61.1%)≥34周孕周、生后早期呼吸衰竭新生儿,生后中位3小时(IQR 2-7小时)行床旁肺超声。
  • 32例(20.4%)需要表面活性物质给药(检验前概率20%)。
  • LUS预测需表面活性物质的AUC为0.87(95%CI 0.81-0.92)。
  • 作为替代检查时LUS>8分总体准确度最高,作为分诊检查时LUS≤4分敏感度最高。
  • 亚组分析:晚期早产儿AUC 0.89(95%CI 0.81-0.97;n=111),早期足月及以后AUC 0.84(95%CI 0.73-0.96;n=46)。
  • 校正孕周后LUS与SpO2:FiO2显著相关(校正β -10.4;95%CI -14.0至-6.7;P<.001),与OSI显著相关(校正β 0.2;95%CI 0.1-0.3;P<.001)。

证据类型、等级与局限

  • 证据类型:前瞻性、国际、多中心诊断研究。

对床旁实践的改变

  • 作者认为,LUS>8分与最高总体准确度相关,可用于指导≥34周呼吸衰竭新生儿的表面活性物质给药。
  • 作者认为,LUS≤4分时该人群需要表面活性物质的可能性不大。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Surfactant administration may be needed in late preterm through full-term neonates, but the pathophysiology of their respiratory failure can be different from that of early preterm neonates. The lung ultrasonography score (LUS) is accurate to guide surfactant replacement in early preterm neonates, but to our knowledge, it has not yet been studied in the late preterm through full-term neonatal population.

OBJECTIVE: To assess whether LUS is equally accurate to predict surfactant need in late preterm through full-term neonates as in early preterm neonates.

DESIGN, SETTING, AND PARTICIPANTS: This prospective, international, multicenter diagnostic study was performed between December 2022 and November 2023 in tertiary academic neonatal intensive care units in France, Italy, Spain, and the US. Late preterm through full-term neonates (≥34 weeks' gestation) with respiratory failure early after birth were enrolled.

EXPOSURE: Point-of-care lung ultrasonography to calculate the neonatal LUS (range, 0-18, with higher scores indicating worse aeration), which was registered in dedicated research databases and unavailable for clinical decision-making.

MAIN OUTCOMES AND MEASURES: The main outcomes were the area under the curve (AUC) in receiver operating characteristic analysis and derived accuracy variables, considering LUS as a replacement for other tests (ie, highest global accuracy) and as a triage test (ie, highest sensitivity). Sample size was calculated to assess noninferiority of LUS to predict surfactant need in the study population compared with neonates born more prematurely. Correlations of LUS with the ratio of hemoglobin oxygen saturation as measured by pulse oximetry (SpO2) to fraction of inspired oxygen (FiO2) and with the oxygen saturation index (OSI) were assessed.

RESULTS: A total of 157 neonates (96 [61.1%] male) were enrolled and underwent lung ultrasonography at a median of 3 hours (IQR, 2-7 hours) of life; 32 (20.4%) needed surfactant administration (pretest probability, 20%). The AUC was 0.87 (95% CI, 0.81-0.92). The highest global accuracy and sensitivity were reached for LUS values higher than 8 or 4 or lower, respectively. Subgroup analysis gave similar diagnostic accuracy in neonates born late preterm (AUC, 0.89; 95% CI, 0.81-0.97; n = 111) and early term and later (AUC, 0.84; 95% CI, 0.73-0.96; n = 46). After adjusting for gestational age, LUS was significantly correlated with SpO2:FiO2 (adjusted β, -10.4; 95% CI, -14.0 to -6.7; P < .001) and OSI (adjusted β, 0.2; 95% CI, 0.1-0.3; P < .001).

CONCLUSIONS AND RELEVANCE: In this diagnostic study of late preterm through full-term neonates with respiratory failure early after birth, LUS accuracy to predict surfactant need was not inferior to that observed in earlier preterm neonates. An LUS higher than 8 was associated with highest global accuracy (replacement test), suggesting that it can be used to guide surfactant administration. An LUS value of 4 or lower was associated with the highest sensitivity (triage test), suggesting it is unlikely for this population to need surfactant.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. De Luca D, Bonadies L, Alonso-Ojembarrena A, et al. Quantitative Lung Ultrasonography to Guide Surfactant Therapy in Neonates Born Late Preterm and Later. JAMA Netw Open. 2024. PMID: 38805223. doi:10.1001/jamanetworkopen.2024.13446

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。